Search Results - carl+wagner

11 Results

Sort By:

  1. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions.There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
    Keywords(s):  
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Non-Cancer Therapeutics, Neurodegenerative Disease Technologies, Pharmaceuticals
  2. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Simulation, Therapeutics
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  3. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
    Keywords(s): Bio-Technology
    Category(s): Life Science (All LS Techs), Cancer Therapeutics, Pharmaceuticals, Neurodegenerative Disease Technologies, Non-Cancer Therapeutics
  4. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Pamela Marshall, Peter Jurutka, Carl Wagner
    Keywords(s): Therapeutics
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  5. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
    Keywords(s): Cancer, Diabetes, Parkinson's Disease
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  6. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Cancer, Diabetes, Parkinson's Disease
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  7. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Therapeutics
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  8. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s):  
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  9. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Drug Screening
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  10. Compositions and Extracts with Antiviral Activity
    For the past half a century, alternative therapies to diseases have been increasingly sought in the US and globally. A 2002 study estimated 19 percent of adults used a botanical therapy to treat illnesses or conditions and that number seems to be rising. Isolating the active compounds of many botanicals offers novel treatment possibilities for a myriad...
    Published: 2/13/2025
    Inventor(s): Thomas Cahill, Jeffrey Langland, Bertram Jacobs, Carl Wagner, Guillermo Ruiz
    Keywords(s):  
    Category(s): Life Science (All LS Techs), Vaccines/Antimicrobials, Non-Cancer Therapeutics, Pharmaceuticals

Search Inventions

Looking for a technology or invention to commercialize? Arizona State University has more than 300 technologies available for licensing. Start your search here or submit your own invention.